XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Statements of Operations - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]            
Net sales $ 883,000 $ 895,000 $ 3,370,000 $ 2,775,000 $ 3,655,000 $ 3,872,000
Cost of goods sold 648,000 536,000 2,362,000 1,805,000 2,471,000 2,584,000
Gross profit 235,000 359,000 1,008,000 970,000 1,184,000 1,288,000
Operating expenses:            
Research and development 24,000 23,000 77,000 62,000 82,000 93,000
Selling and marketing 89,000 131,000 408,000 350,000 459,000 545,000
General and administrative 294,000 286,000 951,000 968,000 1,236,000 1,412,000
Total operating expenses 407,000 440,000 1,436,000 1,380,000 1,777,000 2,050,000
Operating loss (172,000) (81,000) (428,000) (410,000) (593,000) (762,000)
Other (expense) / income:            
Interest income 0 0 0 0 0 1,000
Interest expense (42,000) (66,000) (133,000) (200,000) (265,000) (284,000)
Other income, net 0 3,000 0 172,000 172,000 19,000
Total other (expense) / income (42,000) (63,000) (133,000) (28,000) (93,000) (264,000)
Net loss before tax (214,000) (144,000) (561,000) (438,000) (686,000) (1,026,000)
Income tax expense (2,000) 0 (2,000) (2,000) 5,000 (2,000)
Net loss $ (216,000) $ (144,000) $ (563,000) $ (440,000) $ (681,000) $ (1,028,000)
Basic and diluted loss per common share $ (0.01) $ 0 $ (0.02) $ (0.01) $ (0.02) $ (0.03)
Weighted average number of shares outstanding - basic & diluted 35,953,476 32,545,776 35,278,455 32,479,123 32,526,669 30,115,063